Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 236

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 236
---
 the Purchaser with copies of all written correspondence between the Company and its Representatives, on the 
 one hand, and the Securities Authority or the staff of the Securities Authority, on the other hand. The Company shall use its commercially reasonable efforts to respond reasonably promptly to any correspondence with respect to the Circular or the    
 Arrangement from any Securities Authority or the staff of a Securities Authority with respect to the Circular or the Arrangement, and the Company shall give reasonable consideration to recommendations provided by the Purchaser and its legal counsel  
 prior to submitting to the Securities Authority or the staff of the Securities Authority any response to any such correspondence. In connection with the filing of the Circular or the dissemination thereof to the Shareholders, or submitting to any    
 Securities Authority or the staff of a Securities Authority any response to any correspondence of any Securities Authority or the staff of the Securities Authority with respect thereto, the Company shall provide the Purchaser and its outside legal   
 counsel a reasonable opportunity to review and comment on such document, responses and/or proposed disclosures and the Company shall give reasonable and due consideration to any reasonable comments of the Purchaser and/or its outside legal counsel   
 prior to such filing, dissemination or submission.                                                                                                                                                                                                        |

| 2.5 | Meeting |

Subject to the terms of this Agreement and the Interim Order, the Company shall:

| (a) | convene and conduct the Meeting in accordance with the Interim Order, the Company’s Constating Documents 
 and Law, as soon as reasonably practicable (and in any event, but subject to availability                |

A-22

| of the Court for the Interim Order, on or before the later of: (A) 75 days following the date of this Agreement and (B) 45 days following the SEC Clearance Period (the “Meeting                                                            
 Deadline”)), for the purpose of considering the Arrangement Resolution, the Alternate Resolution and for any other proper purpose as may be set out in the Circular and agreed to by the Purchaser, and not adjourn, postpone or cancel (or 
 propose the adjournment, postponement or cancellation of) the Meeting without the prior written consent of the Purchaser, except:                                                                                                           |

| (i) | in the case of an adjournment, as required for quorum purposes; or |

| (ii) | as required or permitted under Section 6.2(f); |

| (b) | give notice to the Purchaser of the Meeting and allow the Purchaser’s Representatives and outside legal 
 counsel to attend